doi: 10.1186/s13024-019-0333-5 6 ReyesMGFaraldiFRydmanRCe WangC
Retatrutide is still undoing clinical trials, so the full range of side effects may not be fully understood
Patients with contraindications - including personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, pancreatitis history, severe GI or kidney disease, pregnancy, or breastfeeding - won't be approved
PT-141 / 10mg PT-141, also known as bremelanotide, is a synthetic melanocortin-receptor peptide studied for its relevance to melanocortin signaling, receptor-binding behavior, central neuropeptide pathway research, and cellular communication models
Administered by Professionals All treatments are performed by licensed professionals in a safe and comfortable setting